Fluorescence in situ hybridization for MDM2 amplification as a routine ancillary diagnostic tool for suspected well-differentiated and dedifferentiated liposarcomas: Experience at a tertiary center

Sarcoma

Volumn 2015, Issue , 2015, Pages

  Thway, Khin ^a   Wang, Jayson ^a   Swansbury, John ^b   Min, Toon ^b   Fisher, Cyril ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL; ADOLESCENT; ADULT; AGED; ARM; ARTICLE; AXILLA; BACK; BREAST; BUTTOCK; CANCER LOCALIZATION; CANCER SIZE; CARCINOMA; CHILD; DEDIFFERENTIATED LIPOSARCOMA; DIFFERENTIAL DIAGNOSIS; EAR; FAT NECROSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOOT; FOREHEAD; GENE; GENE AMPLIFICATION; HIBERNOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INGUINAL REGION; INTESTINE; JAW; KNEE; LEIOMYOSARCOMA; LIPOBLASTOMA; LIPOMA; LIPOMATOSIS; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MDM2 GENE; MEDIASTINUM; MESENTERY; MOUTH; OSTEOSARCOMA; PELVIS; PERINEUM; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; RETROPERITONEUM; RHABDOMYOSARCOMA; SCALP; SOLITARY FIBROUS TUMOR; SPERMATIC CORD; SPINDLE CELL; SPINDLE CELL SARCOMA; THIGH; THORAX; THORAX WALL; TUMOR BIOPSY; WELL DIFFERENTIATED LIPOSARCOMA;

EID: 84924599048     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2015/812089     Document Type: Article

References (48)

1. J. R. Goldblum, A. L. Folpe, and S. W. Weiss, "Benign lipomatous tumors", in Enzinger and Weiss's Soft Tissue Tumors, pp. 443-483, Elsevier, New York, NY, USA, 6th edition, 2014.
2. A. G. Nascimento, "Dedifferentiated liposarcoma", Seminars in Diagnostic Pathology, vol. 18, no. 4, pp. 263-266, 2001.
3. L. Laurino, A. Furlanetto, E. Orvieto, and A. P. D. Tos, "Welldifferentiated liposarcoma (atypical lipomatous tumors)", Seminars in Diagnostic Pathology, vol. 18, no. 4, pp. 258-262, 2001.
4. K. Thway and C. Fisher, "Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre", Sarcoma, vol. 2009, Article ID 741975, 7 pages, 2009.
5. Z. K. Arbiser, A. L. Folpe, and S. W. Weiss, "Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations", The American Journal of Clinical Pathology, vol. 116, no. 4, pp. 473-476, 2001.
6. W. H. Henricks, Y. C. Chu, J. R. Goldblum, and S. W. Weiss, "Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation", The American Journal of Surgical Pathology, vol. 21, no. 3, pp. 271-281, 1997.
7. M. D. Kraus, L. Guillou, and C. D. M. Fletcher, "Welldifferentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma", The American Journal of Surgical Pathology, vol. 21, no. 5, pp. 518-527, 1997.
8. A. Mariño-Enríquez, C. D. M. Fletcher, P. D. Cin, and J. L. Hornick, "Dedifferentiated liposarcoma with 'homologous' lipoblastic (Pleomorphic Liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria", American Journal of Surgical Pathology, vol. 34, no. 8, pp. 1122-1131, 2010.
9. R. S. A. de Vreeze, D. de Jong, I. H. G. Tielen et al., "Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis", Modern Pathology, vol. 22, no. 2, pp. 223-231, 2009.
10. V. Billing, F. Mertens, H. A. Domanski, and A. Rydholm, "Deep-seated ordinary and atypical lipomas: histopathology, cytogenetics, clinical features, and outcome in 215 tumours of the extremity and trunk wall", The Journal of Bone and Joint Surgery: British Volume, vol. 90, no. 7, pp. 929-933, 2008.
11. J. W. Serpell and R. Y. Y. Chen, "Review of large deep lipomatous tumours", ANZ Journal of Surgery, vol. 77, no. 7, pp. 524-529, 2007.
12. D. McCormick, T. Mentzel, A. Beham, and C. D. M. Fletcher, "Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas", The American Journal of Surgical Pathology, vol. 18, no. 12, pp. 1213-1223, 1994.
13. C. R. Antonescu, "The role of genetic testing in soft tissue sarcoma", Histopathology, vol. 48, no. 1, pp. 13-21, 2006.
14. F. S. Leach, T. Tokino, P. Meltzer et al., "p53 mutation and MDM2 amplification in human soft tissue sarcomas", Cancer Research, vol. 53, no. 10, supplement, pp. 2231-2234, 1993.
15. P. Dal Cin, P. Kools, R. Sciot et al., "Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors", Cancer Genetics and Cytogenetics, vol. 68, no. 2, pp. 85-90, 1993.
16. S. Pilotti, G. della Torre, C. Lavarino et al., "Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms", The Journal of Pathology, vol. 181, no. 1, pp. 14-24, 1997.
17. M. Nilbert, A. Rydholm, F. Mitelman, P. S. Meltzer, and N. Mandahl, "Characterization of the 12q13-15 amplicon in soft tissue tumors", Cancer Genetics and Cytogenetics, vol. 83, no. 1, pp. 32-36, 1995.
18. F. Pedeutour, R. F. Suijkerbuijk, A. Forus et al., "Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma", Genes Chromosomes and Cancer, vol. 10, no. 2, pp. 85-94, 1994.
19. J. S. Wunder, K. Eppert, S. R. Burrow, N. Gogkoz, R. S. Bell, and I. L. Andrulis, "Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas", Oncogene, vol. 18, no. 3, pp. 783-788, 1999.
20. A. Neuville, F. Collin, P. Bruneval et al., "Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas", The American Journal of Surgical Pathology, vol. 38, no. 4, pp. 461-469, 2014.
21. J. Weaver, E. Downs-Kelly, J. R. Goldblum et al., "Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms", Modern Pathology, vol. 21, no. 8, pp. 943-949, 2008.
22. T. Nakayama, J. Toguchida, B.-I. Wadayama, H. Kanoe, Y. Kotoura, and M. S. Sasaki, "MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors", International Journal of Cancer, vol. 64, no. 5, pp. 342-346, 1995.
23. J. Rosai, M. Akerman, P. Dal Cin et al., "Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (A report of the CHAMP study group)", The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1182-1189, 1996.
24. J.-M. Coindre, F. Pédeutour, and A. Aurias, "Well-differentiated and dedifferentiated liposarcomas", Virchows Archiv, vol. 456, no. 2, pp. 167-179, 2010.
25. A. E. Horvai, S. Devries, R. Roy, R. J. O'Donnell, and F. Waldman, "Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma", Modern Pathology, vol. 22, no. 11, pp. 1477-1488, 2009.
26. A. P. dei Tos, C. Doglioni, S. Piccinin et al., "Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours", The Journal of Pathology, vol. 190, no. 5, pp. 531-536, 2000.
27. I. Hostein, M. Pelmus, A. Aurias, F. Pedeatour, S. Mathoulin-Pélissier, and J. M. Coindre, "Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded metarial: a potential tool for the diagnosis of atypical lipomatous tomours/well-defferentiated liposarcomas", Journal of Pathology, vol. 202, no. 1, pp. 95-102, 2004.
28. S. Shimada, T. Ishizawa, K. Ishizawa, T. Matsumura, T. Hasegawa, and T. Hirose, "The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers", Human Pathology, vol. 37, no. 9, pp. 1123-1129, 2006.
29. N. Sirvent, J.-M. Coindre, G. Maire et al., "Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR", The American Journal of Surgical Pathology, vol. 31, no. 10, pp. 1476-1489, 2007.
30. P. B. Aleixo, A. A. Hartmann, I. C. Menezes, R. T. Meurer, and A. M. Oliveira, "Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours", Journal of Clinical Pathology, vol. 62, no. 12, pp. 1127-1135, 2009.
31. M. B. N. Binh, X. Sastre-Garau, L. Guillou et al., "MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data", The American Journal of Surgical Pathology, vol. 29, no. 10, pp. 1340-1347, 2005.
32. M. He, S. Aisner, J. Benevenia, F. Patterson, H. Aviv, and M. Hameed, "p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deepseated lipoma", Applied Immunohistochemistry and Molecular Morphology, vol. 17, no. 1, pp. 51-56, 2009.
33. S. Pilotti, G. D. Torre, A. Mezzelani et al., "The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma", British Journal of Cancer, vol. 82, no. 7, pp. 1271-1275, 2000.
34. K. Thway, R. Flora, C. Shah, D. Olmos, and C. Fisher, "Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors", The American Journal of Surgical Pathology, vol. 36, no. 3, pp. 462-469, 2012.
35. M. B. N. Binh, X. S. Garau, L. Guillo, A. Aurias, and J.-M. Coindre, "Reproducibility of MDM2 and CDK4 staining in soft tissue tumors", The American Journal of Clinical Pathology, vol. 125, no. 5, pp. 693-697, 2006.
36. K. Thway, S. Rockcliffe, D. Gonzalez et al., "Utility of sarcomaspecific fusion gene analysis in paraffin-embedded material for routine diagnosis at a specialist centre", Journal of Clinical Pathology, vol. 63, no. 6, pp. 508-512, 2010.
37. H. Zhang, M. Erickson-Johnson, X. Wang et al., "Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors", The American Journal of Surgical Pathology, vol. 34, no. 9, pp. 1304-1311, 2010.
38. J. Cho, S. E. Lee, and Y.-L. Choi, "Diagnostic value of MDM2 and DDIT3 fluorescence In Situ hybridization in liposarcoma classification: a single-institution experience", Korean Journal of Pathology, vol. 46, no. 2, pp. 115-122, 2012.
39. Y. Miura, Y. Keira, J. Ogino et al., "Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors", Pathology International, vol. 62, no. 1, pp. 16-27, 2012.
40. H. Kimura, Y. Dobashi, T. Nojima et al., "Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics", International Journal of Clinical and Experimental Pathology, vol. 6, no. 7, pp. 1306-1316, 2013.
41. T. Kashima, D. Halai, H. Ye et al., "Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor", Modern Pathology, vol. 25, no. 10, pp. 1384-1396, 2012.
42. A. Neuville, D. Ranchère-Vince, A. P. Dei Tos et al., "Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study", The American Journal of Surgical Pathology, vol. 37, no. 8, pp. 1259-1268, 2013.
43. J.-M. Coindre, O. Mariani, F. Chibon et al., "Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma", Modern Pathology, vol. 16, no. 3, pp. 256-262, 2003.
44. J. C. Fanburg-Smith and M. Miettinen, "Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma", Histopathology, vol. 33, no. 5, pp. 414-424, 1998.
45. A. G. Nascimento, P. J. Kurtin, L. Guillou, and C. D. M. Fletcher, "Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation", The American Journal of Surgical Pathology, vol. 22, no. 8, pp. 945-955, 1998.
46. M. Hisaoka, S. Tsuji, H. Hashimoto, T. Aoki, and K. Uriu, "Dedifferentiated liposarcoma with an inflammatory malignant fibrous histiocytoma-like component presenting a leukemoid reaction", Pathology International, vol. 47, no. 9, pp. 642-646, 1997.
47. R. S. MacArenco, M. Erickson-Johnson, X. Wang et al., "Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas?: a clinicopathologic and molecular study of 19 cases", The American Journal of Surgical Pathology, vol. 33, no. 10, pp. 1470-1476, 2009.
48. S. Le Guellec, F. Chibon, M. Ouali et al., "Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?" The American Journal of Surgical Pathology, vol. 38, no. 3, pp. 293-304, 2014.